Skip to main content
Clinical Trials/NCT02459470
NCT02459470
Completed
Not Applicable

Utility of Stroke Volume Variation and Pulse Pressure Variation for Predicting Fluid Responsiveness in Chronic Renal Failure Patients Undergoing Kidney Transplantation

Samsung Medical Center1 site in 1 country42 target enrollmentDecember 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Transplantation
Sponsor
Samsung Medical Center
Enrollment
42
Locations
1
Primary Endpoint
stroke volume variation from Flo stroke volume variation from FloTrac/Vigileo system
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The aim pf this prospective study is to investigate the ability of stroke volume variation (SVV) and pulse pressure variation (PPV) to predict fluid responsiveness in patients undergoing kidney transplantation.

Detailed Description

Optimal intraoperative fluid management guided by central venous pressure (CVP), a traditional intravascular volume status indicator has been established to improve transplanted graft function during renal transplantation. Recently, stroke volume variation (SVV) and pulse pressure variation (PPV), dynamic preload indices derived from the arterial waveform are increasingly advocated as predictors of fluid responsiveness in anesthetized patients and critically ill patients. However, their usefulness in renal failure patients undergoing renal transplantation has not been investigated. Thus, the aims of this study is to investigate accuracy of SVV and PPV for predicting fluid responsiveness in patients undergoing kidney transplantation.

Registry
clinicaltrials.gov
Start Date
December 2012
End Date
December 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • chronic renal failure patients undergoing renal transplantation

Exclusion Criteria

  • patients with cardiac arrhythmia
  • patients with reduced left ventricular function (EF \< 40%)
  • patients with valvular heart disease
  • patients intracardiac shunt
  • patients with pulmonary hypertension
  • patients with extensive peripheral vascular disease
  • patients with preoperative use of vasopressors or inotropics

Outcomes

Primary Outcomes

stroke volume variation from Flo stroke volume variation from FloTrac/Vigileo system

Time Frame: within 5 minutes after fluid expansion

predictable of stroke volume variation from FloTrac/Vigileo system for fluid responsiveness

pulse pressure variation from philips Intelivue MP70 monitor

Time Frame: within 5 minutes after fluid expansion

predictable of pulse pressure variation from philips Intelivue MP70 monitor for fluid responsiveness

Study Sites (1)

Loading locations...

Similar Trials